Conference Day One – Thursday 26 August 2010 |
| |
|
|
| 9:00 |
|
Registration & Refreshments |
| |
|
|
| 10:00 |
|
Opening Remarks from the Chair |
| |
|
|
Global Supply Chain Management |
| 10:10 |
|
Benchmarking your supply chain infrastructure with
international standards and driving cost-effective improvement
to achieve a robust supply chain |
| |
|
- Comparing the pharma SCM scenario in India with international players in terms of:
- Forecasting and planning
- Transport and logistics
- Warehousing and inventory management
- Cold chain infrastructure
- Identifying cost-effective tools and technologies to drive a more robust, streamlined and secure supply chain
- Establishing the optimal set of processes to take the pharma supply chain to the next level
|
|
|
Rishabh Bindlish, Management Consulting SCM Practice
Accenture |
|
|
|
| 10:40 |
|
Developing a fully integrated global pharma supply chain infrastructure to
underpin your export growth strategy
|
| |
|
- Reducing the complexity of your global SCM infrastructure
- Understanding the challenges of accurately monitoring and managing the global supply chain – techniques for achieving end-to-end visibility
- Preparing for the complex demands of multiple regulatory and documentation requirements
|
| |
|
Hemant Kumar, General Manager, Global Supply Chain
Ranbaxy Laboratories |
| |
|
|
| 11:10 |
|
Morning refreshments and networking |
| |
|
|
| 11:40 |
|
Securing your global supply chain to protect the quality and
integrity of high-value pharmaceutical products |
|
|
- Evaluating the global security scenario and the impact on the
pharmaceutical supply chain
- Complying with international standards for product quality and
safety - balancing the investment with increased customer confidence
- Carrying out robust risk assessments of your supply chain
- Evaluating a range of approaches available and determining the most
cost-effective way of remotely monitoring your supply chain
- Comparing and contrasting the effectiveness of track and trace
technologies such as RFID
|
| |
|
Ryan Viegas, Vice President, Supply Chain and Procurement
Watson Pharma |
| |
|
|
Goods and Services Tax (GST) |
| 12:10 |
|
Understanding the implications of the emerging Goods and
Services Tax (GST) on your supply chain operation
|
| |
|
- The impact of impending GST rules on the supply chain as compared
with existing tax rules
- Pinpointing the aspects of the supply chain that will be most affected by
GST
- Modifying your current supply chain structure for minimising tax impact
|
| |
|
Parind Mehta, Partner - Indirect Tax
B S R and Company |
| |
|
|
| 12:40 |
|
Evaluating the impact of the Goods and Services Tax (GST) on
the operational and organisational aspects of the supply chain |
| |
|
- Identifying how GST will bring about new business rules that reduce
supply chain costs
- Re-evaluating the policies that have been affected by GST
implementation and how to work around them
- Understanding the impact of the evolving supply chain on the
organisation and identifying ways of enhancing the overall business
|
| |
|
Ravind Mithe, Executive Director, Consulting
PricewaterhouseCoopers |
| |
|
|
| 13:10 |
|
Lunch and Networking |
| |
|
|
Procurement |
| 14:10 |
|
Revisiting the balance in topline and bottomline through
sustainable procurement - From Total Cost of
Ownership (TCO) to Total Cost of Availability (TCA) |
| |
|
- Recognising procurement not just as a cost differentiator but as an On
Time in Full (OTIF) enabler
- Focusing on vendor capacity evaluation to align with organisational
growth ambitions
- Shifting from a pure costing or savings driven mindset to a business
proposition leading to topline growth
- Integrating procurement with the S&OP process, taking it to the
forefront of your organisation
|
| |
|
Prashant Sharma, Senior Vice President, Global Demand & Supply Organisation
Zydus Cadila |
| |
|
|
Forecasting and Planning |
| 14:40 |
|
Applying advanced forecasting methodologies to ensure the accuracy and cost-
efficiency of the planning process |
| |
|
-
Assessing the long term viability of forecasting methodologies in a fast changing and global pharmaceutical industry
- Determining the potential of new forecasting methodologies and understanding how they can be applied to achieve accuracy of forecast and planning
- Ensuring the integrity of your data inputs
|
| |
|
RSV Rao, Director, Supply Chain
AstraZeneca Pharma India |
| |
|
|
| 15:10 |
|
Fully integrating the forecasting process with your sales, marketing and
operations planning |
| |
|
-
Reviewing best practice integration of the forecast & planning, sales, marketing and production departments
- Understanding the obstacles in achieving full integration of all functions
- Providing the means for real-time flow of critical information to ensure accuracy of forecasts and cost-efficiency of plans
|
| |
|
Siddhartha Pahwa, President, Global Supply Chain |
| |
|
Piramal Healthcare |
| |
|
|
| 15:40 |
|
Afternoon refreshments and networking |
| |
|
|
| 16:10 |
|
Overcoming the challenges of achieving accurate forecasts for
new product launches |
| |
|
- Understanding the specific forecasting challenges associated with new pharmaceutical product launches
- Identifying useful sources of information to inform your forecasting and planning process
- Taking fluctuations in global demand into account and extrapolating effectively in an uncertain global pharmaceutical environment
|
| |
|
Debabrata Gupta, Director and Chief Operating Officer
USV |
| |
|
|
Transport and Logistics |
| 16:40 |
|
Applying the latest tools and techniques to ensure cost-effective logistics
management across India
|
| |
|
-
Assessing the latest tools and techniques for planning out your logistics strategy across a wide geographical area
- Overcoming the challenges of planning around variable transport infrastructure
- Planning for on-time delivery, cost-efficiency and maintaining product quality
- Balancing technology investment with return on investment
|
| |
|
Masud Shaikh, Head Distribution and Logistics
Alembic |
| |
|
|
| 17:10 |
|
Determining the optimal mix of transport to ensure the cost-effective
movement of goods across rural areas
|
| |
|
- Assessing the most reliable mix of transport channels to ensure the swift and cost-effective transfer of goods around the country
- Updating on the Government’s plan for infrastructure development in rural areas
- Exploring opportunities for utilizing the railway system for secure and cost-effective transportation of pharmaceutical goods
- Understanding how ports need to be developed to better serve the transportation needs of the export focused pharmaceutical industry
- Evaluating alternative modes of transport for highly sensitive pharmaceutical products
|
| |
|
Maulik Mehta, Senior Manager, Planning and Logistics
Intas Biopharmaceuticals |
| |
|
|
| 17:40 |
|
Closing remarks from chair |
| |
|
|
| 17:50 |
|
End of conference day one |
| |
|
|
Conference Day Two – Friday 27 August 2010 |
| |
|
|
| 9:00 |
|
Registration & Refreshments |
| |
|
|
| 10:00 |
|
Opening Remarks from the Chair |
| |
|
|
Partnerships with 3PL and 4PL Operators |
| 10:10 |
|
Leveraging win-win partnerships with 3PL/4PL operators to ensure a cost-effective, reliable and a consolidated regional supply chain |
| |
|
- Determining the benefits and risks of outsourcing your back-end SCM to a 3PL / 4PL
- Calculating the financial gains to be made from an outsourcing model which covers regulatory affairs, release, warehousing and distribution
- Retaining the optimal level of control over the supply chain when working with a 3PL/ 4PL partner
- Evaluating the benefits of centralised vendor integration in the areas of compliance, efficiency, traceability and speed to minimise dependence on multiple vendors and costs
|
| |
|
European Healthcare Services |
| |
|
|
| 10:40 |
|
Building 3PL relationships that enable you to guarantee on-time delivery, meet customer expectations, and underpin your organisation's overall financial objectives |
| |
|
- Setting out clear partnership parameters and service level agreements to ensure consistently high levels of service
- Leveraging opportunities in bonded warehousing to make faster off shelf delivery
- Calculating the performance of your supply chain with respect to speed, execution and accuracy
- Continuously evaluating industry standards and developing benchmarking practices to create the supply chain of international standards
- Case studies of managing the operations of companies dealing with high purity chemicals and reagents
|
| |
|
Jeevan Raosahib, Managing Director
Indelox Services |
| |
|
|
Warehousing and Inventory |
| 11:10 |
|
Developing a cost-effective warehousing system for the effective
storage of complex pharma products |
| |
|
- Understanding the complex relationships between warehouse
processes, supply chain strategy and warehouse design
- Identifying the key criteria that should drive the design and architecture
of your warehousing network
- Determining the pros and cons of a centralised versus distributed
architecture
- Planning for fluctuations in product demand across the country and
building in flexibility
- Evaluating a range of technologies like material handling equipment,
mobile storage solutions and inventory management systems, that are
best suited to your supply chain strategy
- Integrating warehousing processes with the overall business processes
of the organisation using IT
|
| |
|
Dr Ravi Prakash Mathur, Director SCM, Head of Logistics
Dr Reddy’s Laboratories |
|
|
|
| 11:40 |
|
Morning refreshments and networking |
| |
|
|
| 12:10 |
|
Identifying advances in inventory management to optimise stock
levels and manage the flow of products |
| |
|
- Examining the challenges faced by pharma companies in managing
their supply and taking care of fluctuations in demand and lead time
- Evaluating the traditional ways of inventory management like materials
requirement planning and their negative impact on the supply chain
- Overview of global best practices to maintain a balance between
demand and supply and achieve minimum inventory cost
- Identifying the latest inventory management tools and technologies to
ensure a robust and cost-effective global supply chain
|
| |
|
Rajendra Tiwari, Chief Administrative Officer
Bayer Healthcare |
| |
|
|
Cold Chain Management |
| 12:40 |
|
Creating a cold chain culture in India to overcome the
challenges faced by pharmaceutical and biopharmaceutical
companies |
| |
|
- Understanding and communicating the importance of cold chain in the
pharma industry
- Identifying the challenges in the current cold chain especially in the
biopharmaceutical companies
- Analysing the various infrastructure challenges
- Training personnel to create a cold chain culture
|
| |
|
Mukta Arora, Director Global Sourcing and Global External R&D
Lilly |
| |
|
|
| |
|
|
| 13:10 |
|
Developing an end-to-end cold chain infrastructure to ensure the
quality and safety of biopharmaceutical products when switching
between modes of transport |
| |
|
- Identifying the challenges associated with transfer of temperature sensitive goods across different climatic conditions and modes of transport
- Evaluating options for achieving a consistent temperature level across the end-to-end supply chain
- Determining robust means of tracking temperature fluctuations in real time
- Leveraging advanced packaging solutions for effective cold chain
management
- Evaluating viable power back-up options to ensure the consistency of
the cold chain
|
| |
|
|
| 13:40 |
|
Lunch and networking |
| |
|
|
| 14:40 |
|
Optimising cold chain warehousing and logistics strategies to
maximise network agility and control |
| |
|
- Understanding the challenges associated with maintaining temperature
control throughout your warehousing network
- Segmenting your warehouse according to product temperature
requirements whilst optimising space utilisation
- Evaluating cost-effective strategies to optimise network agility and reach
for cold chain distribution
|
| |
|
Daryll Mascarenhas, CPIM, General Manager, Supply Chain
GlaxoSmithKline Pharmaceuticals |
| |
|
|
| 15:10 |
|
Establishing and enforcing a stringent process for monitoring
and maintaining temperature control across the end-to-end
supply chain |
| |
|
- Evaluating current processes for monitoring, managing and ensuring
consistent temperature control throughout the chain
- Identifying the key vulnerabilities in the process
- Devising cost-effective processes to establish and enforce good
temperature control practices
|
| |
|
Rajiv Sharma, General Manager, Supply Chain
Panacea Biotec |
| |
|
|
SCM Tools and Technologies |
| 15:40 |
|
Evaluating the latest SCM tools and technologies to ensure a
streamlined, cost-effective, and highly functional global supply
chain |
| |
|
- Examining the latest functionalities available through advanced SCM
tools and how these can be applied to the pharmaceutical supply chain
- Streamlining the supply chain through advanced SCM tools and
technologies
- Achieving end-to-end visibility of the global supply chain
- Plugging your supplier base into your SCM to ensure proactive transfer
of critical delivery data
- Measuring the tangible benefits of SCM software investment and
demonstrating the benefits to the wider organisation
|
| |
|
Nihar Medh, Director, Supply Chain Management
Dr Reddy’s Laboratories |
| |
|
|
| 16:10 |
|
Afternoon refreshments |
| |
|
|
| 16:40 |
|
Fully integrating the latest SCM systems with legacy ERP
systems - maximising functionality and minimising cost |
| |
|
- Understanding the benefits of SCM over and above legacy ERP systems
for the supply chain
- Determining the optimal level of integration to achieve good visibility of
your supply chain
- Overcoming operational challenges of achieving smooth integration of
the two systems
|
| |
|
Speaker to be confirmed |
| |
|
|
Sustainable Supply Chain |
| 17:10 |
|
Driving sustainability through the pharmaceutical supply chain |
| |
|
- Developing a responsible supply chain network in your organisation in
the areas of:
- Ethics
- Labour
- Health, safety and environment
- Evaluating ways of developing Corporate Social Responsibility (CSR)
in the supply chain network
|
| |
|
Pharma Supply Chain Initiative (PSCI) |
| |
|
|
| 17:40 |
|
Closing remarks from chair |
| |
|
|
| 17:50 |
|
End of conference |
| |
|
|